Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study.

Stefan PschererHelmut AndertenMartin PfohlAndreas FritscheAnja BorckKatrin PegelowPeter BramlageJochen Seufert

Published in: Acta diabetologica (2019)

In real-world, titration of Gla-100 during the first month appears to coincide with a number of baseline factors. Insulin dose to meet HbA1c and FBG targets remains suboptimal in the majority of T2D patients.

Keyphrases

type diabetes
end stage renal disease
glycemic control
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
insulin resistance
weight loss
drug induced